The Predictive Value of Plasma Galectin-3 for Ards Severity and Clinical Outcome

Phua, 2009, Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review, Am J Respir Crit Care Med, 179, 220, 10.1164/rccm.200805-722OC

Blank, 2011, Epidemiology of ARDS and ALI, Crit Care Clin, 27, 439, 10.1016/j.ccc.2011.05.005

Mikkelsen, 2013, The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis, Shock, 40, 375, 10.1097/SHK.0b013e3182a64682

Peek, 2009, Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial, Lancet, 374, 1351, 10.1016/S0140-6736(09)61069-2

Gattinoni, 2001, Effect of prone positioning on the survival of patients with acute respiratory failure, N Engl J Med, 345, 568, 10.1056/NEJMoa010043

Martin, 1995, Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients, Chest, 107, 196, 10.1378/chest.107.1.196

Papazian, 2007, A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients, Crit Care Med, 35, 755, 10.1097/01.CCM.0000257325.88144.30

Burnham, 2014, The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance, Eur Respir J, 43, 276, 10.1183/09031936.00196412

Cabrera-Benitez, 2014, Mechanical ventilation-associated lung fibrosis in acute respiratory distress syndrome, Anesthesiology, 121, 189, 10.1097/ALN.0000000000000264

Li, 2014, Functions of galectin-3 and its role in fibrotic diseases, J Pharmacol Exp Ther, 351, 336, 10.1124/jpet.114.218370

Liu, 2007, The role of galectin-3 in promotion of the inflammatory response, Drug News Perspect, 20, 455, 10.1358/dnp.2007.20.7.1149628

de Boer, 2012, The fibrosis marker galectin-3 and outcome in the general population, J Intern Med, 272, 55, 10.1111/j.1365-2796.2011.02476.x

Henderson, 2008, Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis, Am J Pathol, 172, 288, 10.2353/ajpath.2008.070726

Yu, 2013, Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis, Circ Heart Fail, 6, 107, 10.1161/CIRCHEARTFAILURE.112.971168

Lok, 2013, Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure, Clin Res Cardiol, 102, 103, 10.1007/s00392-012-0500-y

Lok, 2010, Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study, Clin Res Cardiol, 99, 323, 10.1007/s00392-010-0125-y

Mackinnon, 2012, Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3, Am J Respir Crit Care Med, 185, 537, 10.1164/rccm.201106-0965OC

Ho, 2016, Galectin-3 is associated with restrictive lung disease and interstitial lung abnormalities, Am J Respir Crit Care Med, 194, 77, 10.1164/rccm.201509-1753OC

Sunil, 2015, Regulation of ozone-induced lung inflammation and injury by the beta-galactoside-binding lectin galectin-3, Toxicol Appl Pharmacol, 284, 236, 10.1016/j.taap.2015.02.002

Force, 2012, Acute respiratory distress syndrome: the Berlin definition, JAMA, 307, 2526

Knaus, 1985, APACHE II: a severity of disease classification system, Crit Care Med, 13, 818, 10.1097/00003246-198510000-00009

Thille, 2013, Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies, Lancet Respir Med, 1, 395, 10.1016/S2213-2600(13)70053-5

Nishi, 2007, Role of galectin-3 in human pulmonary fibrosis, Allergol Int, 56, 57, 10.2332/allergolint.O-06-449

Dang, 2012, Tubular atrophy and interstitial fibrosis after renal transplantation is dependent on galectin-3, Transplantation, 93, 477, 10.1097/TP.0b013e318242f40a

O'Seaghdha, 2013, Elevated galectin-3 precedes the development of CKD, J Am Soc Nephrol, 24, 1470, 10.1681/ASN.2012090909

Chen, 2016, Using the galectin-3 test to predict mortality in heart failure patients: a systematic review and meta-analysis, Biomark Med, 10, 329, 10.2217/bmm.15.121

Ho, 2012, Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community, J Am Coll Cardiol, 60, 1249, 10.1016/j.jacc.2012.04.053

Fery-Lemonnier, 1995, Evaluation of severity scoring systems in ICUs--translation, conversion and definition ambiguities as a source of inter-observer variability in Apache II, SAPS and OSF, Intensive Care Med, 21, 356, 10.1007/BF01705416

Polderman, 2001, Accuracy and reliability of APACHE II scoring in two intensive care units Problems and pitfalls in the use of APACHE II and suggestions for improvement, Anaesthesia, 56, 47, 10.1046/j.1365-2044.2001.01763.x

Estenssoro, 2002, Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome, Crit Care Med, 30, 2450, 10.1097/00003246-200211000-00008

Wu, 2004, Cardiac troponin I levels are a risk factor for mortality and multiple organ failure in noncardiac critically ill patients and have an additive effect to the APACHE II score in outcome prediction, Shock, 22, 95, 10.1097/01.shk.0000132484.97424.32